Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis

被引:28
作者
Bai, Yongying [1 ,3 ]
Lin, Huayue [1 ]
Fang, Zanxi [1 ]
Luo, Qing [1 ,2 ]
Fang, Yizhen [1 ]
Su, Yuanhui [1 ]
Hu, Qing [1 ]
Duan, Hongbing [4 ]
Chen, Falin [5 ]
Zhang, Zhong-Ying [1 ,2 ]
机构
[1] Xiamen Univ, Affiliated Zhongshan Hosp, Ctr Clin Lab, Xiamen, Peoples R China
[2] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Peoples R China
[3] Zhejiang Univ, Sch Med, Womens Hosp, Clin Anal Ctr, Hangzhou, Zhejiang, Peoples R China
[4] Xiamen Univ, Affiliated Zhongshan Hosp, Dept Thorac Surg, Xiamen, Peoples R China
[5] Fujian Prov Hosp, Clin Lab Ctr, Fuzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
biomarker; Cyfra21-1; esophageal squamous cell carcinoma; miR-19a; plasma; SURGICAL-TREATMENT; DOWN-REGULATION; TUMOR-MARKERS; CANCER; SERUM; STRATEGIES; MIGRATION; SURVIVAL; TARGET; LIVER;
D O I
10.2217/bmm-2016-0286
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: To investigate whether plasma miR-19a can serve as a biomarker for esophageal squamous cell carcinoma (ESCC) diagnosis and prognosis. Materials & methods: Plasma samples from 89 ESCC, 45 benign lesion patients and 80 healthy controls were subjected to RT-qPCR analyses for miR-19a. In addition, plasma samples from 30 patients were collected before and after surgery for the same analyses. Results: Plasma miR-19a was significantly increased in ESCC patients compared with healthy controls. The sensitivity of miR-19a for early stages of ESCC was 68.09%. Combination of miR-19a and cytokeratin 19 fragment 21-1 (Cyfra21-1) further improved the sensitivity to 78.70%. Moreover, plasma miR-19a level was decreased in patients after surgery. Conclusion: Plasma miR-19a may serve as a potential biomarker that complements Cyfra21-1 in detecting early stages of ESCC.
引用
收藏
页码:431 / 441
页数:11
相关论文
共 35 条
[1]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]   Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years [J].
Ando, N ;
Ozawa, S ;
Kitagawa, Y ;
Shinozawa, Y ;
Kitajima, M .
ANNALS OF SURGERY, 2000, 232 (02) :225-232
[3]   p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins [J].
Boehlig, Levin ;
Friedrich, Maik ;
Engeland, Kurt .
NUCLEIC ACIDS RESEARCH, 2011, 39 (02) :440-453
[4]  
Brockmann JG, 2000, ANTICANCER RES, V20, P4899
[5]  
Brockmann JG, 2000, CLIN CANCER RES, V6, P4249
[6]   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004
[7]   NUMBER AND LOCATION OF POSITIVE NODES, POSTOPERATIVE RADIOTHERAPY, AND SURVIVAL AFTER ESOPHAGECTOMY WITH THREE-FIELD LYMPH NODE DISSECTION FOR THORACIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA [J].
Chen, Junqiang ;
Pan, Jianji ;
Zheng, Xiongwei ;
Zhu, Kunshou ;
Li, Jiancheng ;
Chen, Mingqiang ;
Wang, Jiezhong ;
Liao, Zhongxing .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01) :475-482
[8]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[9]   Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA [J].
Ding, Jie ;
Huang, Shenglin ;
Wu, Shunquan ;
Zhao, Yingjun ;
Liang, Linhui ;
Yan, Mingxia ;
Ge, Chao ;
Yao, Jian ;
Chen, Taoyang ;
Wan, Dafang ;
Wang, Hongyang ;
Gu, Jianren ;
Yao, Ming ;
Li, Jinjun ;
Tu, Hong ;
He, Xianghuo .
NATURE CELL BIOLOGY, 2010, 12 (04) :390-U208
[10]   Role of tumor markers in patients with solid cancers: A critical review [J].
Duffy, Michael J. .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (03) :175-184